INVA logo

Innoviva, Inc. (INVA)

Profile

Full Name

Innoviva, Inc.

Ticker

NASDAQ: INVA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 5, 2004

Indexes

Not included

Website

https://www.inva.com

Employees

127

Key Details

Price

$17.27(0.12%)

Market Cap

Last Dividend

$0.25

TTM Dividend Yield

-

Annual Revenue

$372.51M(14.88% YoY)

Annual EPS

$0.36(-83.56% YoY)

PE Ratio

52.05

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $17.27
    INVA price is $17.27

    30-Day Relative Volume

    1.03
    INVA 30-day relative volume is 1.03

    Price Performance

    Price Most Recent Change

    +0.12%
    INVA price was up +0.12% on Oct 17, 2025

    Price YTD Change

    -0.46%
    INVA price is down -0.46% since January 1st

    Price 1-Year Change

    -14.38%
    INVA price is down -14.38% year-on-year

    Price 3-Year Change

    +27.74%
    INVA price is up +27.74% over the past 3 years

    Price Range

    Price All-Time High

    $34.62
    INVA price is currently -50.11% below its historical high of $34.62

    Price 3-Year Low

    $10.64
    INVA price is currently +62.31% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $1.09B
    INVA market cap is $1.09 billion

    Market Cap 3-Year Change

    +15.37%
    INVA market cap is up +15.37% over the past 3 years

    Market Cap All-Time High

    $3.70B
    INVA market cap is currently -70.58% below its historical high of $3.70 billion

    Market Cap Sector Percentile

    71.75%
    INVA market cap is higher than 71.75% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.67%
    INVA shares outstanding is up +0.67% year-on-year

    Shares Outstanding 3-Year Change

    -9.68%
    INVA shares outstanding is down -9.68% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.19
    INVA beta is 0.19

    200-day SMA

    $18.79
    INVA price is currently -8.11% below its 200-day simple moving average

    50-day SMA

    $19.18
    INVA price is currently -9.97% below its 50-day simple moving average

    14-Day RSI

    37.34
    INVA 14-day relative strength index is 37.34

    Volume

    1.03
    INVA 30-day relative volume is 1.03

    ATR

    $0.53
    INVA average true range is $0.53

    10-day Historical Volatility

    29.24%
    INVA 10-day historical volatility is 29.24%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.25
    INVA last dividend was $0.25 per share, with an ex-dividend date of September 8, 2015

    Next Dividend

    -
    INVA next dividend has not yet been announced

    Dividend per share

    Dividend Per Share

    -
    INVA annual dividend per share value is unknown

    Dividend Per Share Sector Percentile

    -
    INVA annual dividend per share is unknown

    Dividend Per Share 1-Year Change

    -
    INVA annual dividend per share 1-year change is unknown

    Dividend Per Share 3-Year Change

    -
    INVA annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend Yield

    -
    INVA annual dividend yield value is unknown

    Dividend Yield Sector Percentile

    -
    INVA annual dividend yield is unknown

    Other

    Payout Ratio

    0.00%
    INVA annual payout ratio is 0.00%

    Dividends Paid

    $0.00
    INVA annual dividends paid is $0.00

    Free Cash Flow

    $184.42M
    INVA annual free cash flow is $184.42 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $372.51M
    INVA annual revenue is $372.51 million

    Revenue Analysts Estimate

    $379.72M
    INVA annual revenue is currently -1.90% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +14.88%
    INVA annual revenue is up +14.88% year-on-year

    Revenue Sector Percentile

    78.85%
    INVA annual revenue is higher than 78.85% of companies in Healthcare sector

    EPS

    EPS

    $0.36
    INVA annual earnings per share is $0.36

    EPS Analysts Estimate

    $1.43
    INVA annual earnings per share is currently -74.68% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -83.56%
    INVA annual earnings per share is down -83.56% year-on-year

    EPS Sector Percentile

    85.82%
    INVA annual earnings per share is higher than 85.82% of companies in Healthcare sector

    Profit

    Gross Profit

    $296.06M
    INVA annual gross profit is $296.06 million

    Gross Margin

    79.48%
    INVA annual gross profit margin is 79.48%

    Operating Profit

    $166.87M
    INVA annual operating income is $166.87 million

    Operating Margin

    44.80%
    INVA annual operating profit margin is 44.80%

    Net Income

    $23.39M
    INVA annual net profit is $23.39 million

    Net Margin

    6.28%
    INVA annual net profit margin is 6.28%

    Expenses

    Total Expenses

    $191.84M
    INVA annual total expenses is $191.84 million

    Operating Expenses

    $155.25M
    INVA annual total operating expenses is $155.25 million

    Cost Of Goods Sold

    $76.45M
    INVA annual cost of goods sold is $76.45 million

    Selling, General & Administrative Expenses

    $0.00
    INVA annual SG&A is $0.00

    Depreciation & Amortization

    $39.85M
    INVA annual D&A is $39.85 million

    Interest Expense

    $0.00
    INVA annual interest expense is $0.00

    Income Tax

    $14.00M
    INVA annual income tax is $14.00 million

    EBIT & EBITDA

    EBIT

    $59.60M
    INVA annual earnings before interest & taxes is $59.60 million

    EBITDA

    $85.50M
    INVA annual EBITDA is $85.50 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $1.34B
    INVA annual total assets is $1.34 billion

    Non Current Assets

    $746.75M
    INVA annual long term assets is $746.75 million

    Current Assets

    $554.31M
    INVA annual total current assets is $554.31 million

    Cash and Cash Equivalents

    $412.50M
    INVA annual cash & cash equivalents is $412.50 million

    Accounts Receivable

    $86.37M
    INVA annual accounts receivable is $86.37 million

    Inventory

    $33.73M
    INVA annual inventory is $33.73 million

    Liabilities

    Total Liabilities

    $644.33M
    INVA annual total liabilities is $644.33 million

    Long Term Liabilities

    $150.75M
    INVA annual total long term liabilities is $150.75 million

    Current Liabilities

    $236.08M
    INVA annual current liabilities is $236.08 million

    Accounts Payable

    $2.13M
    INVA annual accounts payable is $2.13 million

    Debt

    Total Debt

    $451.10M
    INVA annual total debt is $451.10 million

    Total Debt 1-Year Change

    +0.45%
    INVA annual total debt is up +0.45% year-on-year

    Long Term Debt

    $257.50M
    INVA annual long term debt is $257.50 million

    Short Term Debt

    $193.60M
    INVA annual short term debt is $193.60 million

    Equity & Capital

    Shareholders Equity

    $691.16M
    INVA annual stockholders equity is $691.16 million

    Book Value

    $691.16M
    INVA annual book value is $691.16 million

    Retained Earnings

    -$1.80M
    INVA annual retained earnings is -$1.80 million

    Working Capital

    $318.22M
    INVA annual working capital is $318.22 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $188.69M
    INVA annual cash from operations is $188.69 million

    Cash From Operations 1-Year Change

    +33.76%
    INVA annual cash from operations is up +33.76% year-on-year

    Cash From Investing

    -$63.79M
    INVA annual cash from investing is -$63.79 million

    Cash From Investing 1-Year Change

    +4.46%
    INVA annual cash from investing is up +4.46% year-on-year

    Cash From Financing

    -$13.45M
    INVA annual cash from financing is -$13.45 million

    Cash From Financing 1-Year Change

    +92.17%
    INVA annual cash from financing is up +92.17% year-on-year

    CAPEX

    CAPEX

    $4.27M
    INVA annual capital expenditures is $4.27 million

    CAPEX 1-Year Change

    +938.93%
    INVA annual capital expenditures is up +938.93% year-on-year

    Free Cash Flow

    Free Cash Flow

    $184.42M
    INVA annual free cash flow is $184.42 million

    Free Cash Flow 1-Year Change

    +31.12%
    INVA annual free cash flow is up +31.12% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    79.48%
    INVA annual gross profit margin is 79.48%

    Operating Margin

    44.80%
    INVA annual operating profit margin is 44.80%

    Net Margin

    6.28%
    INVA annual net profit margin is 6.28%

    ROA & ROE

    ROA

    1.81%
    INVA annual return on assets is 1.81%

    ROE

    3.42%
    INVA annual return on equity is 3.42%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    52.05
    INVA price to earnings ratio is 52.05

    PE Ratio Sector Percentile

    80%
    INVA price to earnings ratio is higher than 80% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    1.52
    INVA price to book ratio is 1.52

    PB Ratio Sector Percentile

    43.52%
    INVA price to book ratio is higher than 43.52% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    2.83
    INVA price to sales ratio is 2.83

    PS Ratio Sector Percentile

    43.85%
    INVA price to sales ratio is higher than 43.85% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.11B
    INVA enterprise value is $1.11 billion

    Enterprise Value Sector Percentile

    72.89%
    INVA enterprise value is higher than 72.89% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    5.12
    INVA EV/EBITDA is 5.12

    EV/EBITDA Sector Percentile

    77.17%
    INVA EV/EBITDA is higher than 77.17% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.35
    INVA annual current ratio is 2.35

    Quick Ratio

    2.21
    INVA annual quick ratio is 2.21

    Leverage

    Debt To Equity

    0.65
    INVA annual debt to equity ratio is 0.65

    Interest Coverage Ratio

    -
    INVA annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    6
    INVA piotroski f-score is 6

    Altman Z-Score

    1.72
    INVA altman z-score is 1.72

    Analyst ratings

    Recent major analysts updates

    Sep 30, 25 Goldman Sachs
    Sell
    Aug 11, 25 Oppenheimer
    Outperform
    Aug 11, 25 HC Wainwright & Co.
    Buy
    Jul 14, 25 HC Wainwright & Co.
    Buy
    Jul 11, 25 Cantor Fitzgerald
    Overweight
    Mar 7, 25 Scotiabank
    Sector Outperform
    Aug 1, 24 Cantor Fitzgerald
    Overweight
    Jul 30, 24 Cantor Fitzgerald
    Overweight
    Jun 20, 24 Cantor Fitzgerald
    Overweight
    Jun 18, 24 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with INVA included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Innoviva, Inc.?
    • Does Innoviva, Inc. pay dividends?
    • What sector is Innoviva, Inc. in?
    • What industry is Innoviva, Inc. in?
    • What country is Innoviva, Inc. based in?
    • When did Innoviva, Inc. go public?
    • Is Innoviva, Inc. in the S&P 500?
    • Is Innoviva, Inc. in the NASDAQ 100?
    • Is Innoviva, Inc. in the Dow Jones?
    • When was Innoviva, Inc.'s last earnings report?
    • When does Innoviva, Inc. report earnings?

    What is the ticker symbol for Innoviva, Inc.?

    The ticker symbol for Innoviva, Inc. is NASDAQ:INVA

    Does Innoviva, Inc. pay dividends?

    No, Innoviva, Inc. does not pay dividends

    What sector is Innoviva, Inc. in?

    Innoviva, Inc. is in the Healthcare sector

    What industry is Innoviva, Inc. in?

    Innoviva, Inc. is in the Biotechnology industry

    What country is Innoviva, Inc. based in?

    Innoviva, Inc. is headquartered in United States

    When did Innoviva, Inc. go public?

    Innoviva, Inc.'s initial public offering (IPO) was on October 5, 2004

    Is Innoviva, Inc. in the S&P 500?

    No, Innoviva, Inc. is not included in the S&P 500 index

    Is Innoviva, Inc. in the NASDAQ 100?

    No, Innoviva, Inc. is not included in the NASDAQ 100 index

    Is Innoviva, Inc. in the Dow Jones?

    No, Innoviva, Inc. is not included in the Dow Jones index

    When was Innoviva, Inc.'s last earnings report?

    Innoviva, Inc.'s most recent earnings report was on August 6, 2025

    When does Innoviva, Inc. report earnings?

    The next expected earnings date for Innoviva, Inc. is November 5, 2025
    On this page